Regulacje i polityka gospodarcza · 30/11/1998

NIH Seeks Licensees for Therapeutic Treatment of Primary Brain Tumors

The National Institutes of Health is seeking companies to further develop and commercialize a treatment for refractory brain tumors, including glioma, astrocytomas, medulloblastomas, and metastatic tumors to the central nervous system, using a Transforming Growth Factor-alpha-Pseudomonas Exotoxin fusion protein.